SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic drop today following the unexpected withdrawal of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by nearly 10%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it